The growth of 3d cell culture market is driven mainly by the increasing focus on developing alternatives to animal testing, growing focus on personalized medicine, increasing incidence of chronic diseases, and the availability of funding for research. On the other hand, the lack of infrastructure for 3D cell-based research and the high cost of cell biology research are expected to restrain the growth of this market during the forecast period.
3D Cell Culture Market by Product (Hydrogel, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell, Toxicology, Tissue Engineering), End User (Pharmaceutical, Biotech, Cosmetics), Region.
The global 3D cell culture market size is projected to reach USD 1,846 million in 2024 from USD 892 million in 2019, at a CAGR of 15.7%.
Request Sample Pages:
The Global 3D Cell Culture Market is Segmented on:
3. End User
1. Scaffold-based 3D Cell Cultures
2. Scaffold-free 3D Cell Cultures
3. Microfluidics-based 3D Cell Cultures
4. Magnetic & Bioprinted 3D Cell Cultures
1. Cancer Research
2. Stem Cell Research
3. Drug Discovery
4. Toxicology Testing
5. Tissue Engineering
6. Regenerative Medicine
By End User:
1. Pharmaceutical & Biotechnology Companies
2. Research Institutes
3. Cosmetics Industry
1. North America
3. Asia Pacific
4. Rest of The World
North America commanded the largest share of the market due to the increasing incidence of cancer and the presence of a well-established pharmaceutical & biotechnology industry. However, the market in Europe is expected to grow at the highest CAGR during the forecast period. The growth of the market in Europe is attributed to the growth of its pharmaceutical and biotechnology industry, recent commercialization of microfluidics-based products, the increasing presence of major market players, and a large number of research activities conducted in the region.
Download PDF Brochure:
Thermo Fisher Scientific (US), Corning Incorporated (US), Merck KGaA (Germany), Lonza AG (Switzerland), REPROCELL Incorporated (Japan), TissUse (Germany), InSphero (Switzerland), Synthecon (US), 3D Biotek (US), CN Bio (UK), Hamilton Company (US), MIMETAS (Netherlands), Emulate (US).
Thermo Fisher Scientific is the leading player in the 3D cell culture market. The leading position of the company can be attributed to its strong brand image and robust product portfolio. The company has a strong foothold in the market with its established brand—AlgiMatrix. To maintain its leading position in the market, the company focuses on R&D activities and product launches.